Biotechnologically engineered protein binders for applications in amyloid diseasesHAUPT, Christian; FÄNDRICH, Marcus.Trends in biotechnology (Regular ed.). 2014, Vol 32, Num 10, pp 513-520, issn 0167-7799, 8 p.Article

Assembly of Alzheimer's A3 peptide into nanostructured amyloid fibrilsMORGADO, Isabel; FÄNDRICH, Marcus.Current opinion in colloid & interface science. 2011, Vol 16, Num 6, pp 508-514, issn 1359-0294, 7 p.Article

Amyloid fibrils from muscle myoglobin: Even an ordinary globular protein can assume a rogue guise if conditions are rightFÄNDRICH, Marcus; FLETCHER, Matthew A; DOBSON, Christopher M et al.Nature (London). 2001, Vol 410, Num 6825, pp 165-166, issn 0028-0836Article

Biochemical stages of amyloid-β peptide aggregation and accumulation in the human brain and their association with symptomatic and pathologically preclinical Alzheimer's diseaseAJEET RIJAL UPADHAYA; KOSTERIN, Irina; KUMAR, Sathish et al.Brain. 2014, Vol 137, pp 887-903, issn 0006-8950, 17 p., 3Article

Oligomeric and fibrillar species of β-amyloid (Aβ42) both impair mitochondrial function in P301L tau transgenic miceECKERT, Anne; HAUPTMANN, Susanne; SCHERPING, Isabel et al.Journal of molecular medicine (Berlin. Print). 2008, Vol 86, Num 11, pp 1253-1265, issn 0946-2716, 13 p.Article

Early neuronal dysfunction by amyloid β oligomers depends on activation of NR2B-containing NMDA receptorsRÖNICKE, Raik; MIKHAYLOVA, Marina; RÖNICKE, Sabine et al.Neurobiology of aging. 2011, Vol 32, Num 12, pp 2219-2228, issn 0197-4580, 10 p.Article